Investigator training needed to fuel Indian trial growth

By Nick Taylor

- Last updated on GMT

Related tags Clinical trial

A shortage of investigators with knowledge of trial regulations and ethics is an obstacle to growth of Indian clinical research.

Globalisation of clinical research has seen India, with its large, heterogeneous patient population, emerge as a leading destination for conducting trials. However, some areas, such as investigator training, have failed to keep up with rapid growth in clinical trials and these must be addressed.

In India, there is a lack of potential investigators with fundamental knowledge of regulatory, ethical, GCP (good clinical practice) guidelines to conduct clinical trials​”, says research in the International Journal of Preclinical and Pharmaceutical Research.

Shortages stem from insufficient formal clinical research training in medical schools and a lack of Government-led efforts. Action by these bodies is needed to support sponsor, contract research organisation (CRO) and site management organisation (SMO) led training programmes.

Building a network of Government-regulated clinical trial centres is proposed to support training.

Ethics and informed consent

Developing a pool of trained investigators will help India overcome some of the other challenges, such as informed consent, highlighted in the research. Oversight of the informed consent process is provided by ethics committees and these must be improved to ensure patients are protected.

Improper and unethical performance of ethics committees put many poor, illiterate people of India in grave risk​”, say the researchers. Areas of concern include ethics committees lacking members with non-clinical backgrounds and failing to have a regular schedule of meetings.

Ethics and informed consent in India are complicated by language. Hindi is the dominant language in India but is only spoken by some of the population. Many local languages and dialects are spoken, particularly in rural areas.

This makes recruiting a patient population challenging and it becomes necessary to deliver clinical trial materials in multiple Indic languages​”, say the researchers. Qualified translators are needed to operate in this fragmented linguistic environment.


Efforts are underway to overcome some of the challenges discussed in the research. Laws and the regulatory system are being strengthened, say the researchers, and there is a focused effort to increase training of clinical trial professionals.

India is poised to offer the global pharmaceutical industry high quality and cost-effective contract services to support drug discovery, clinical trial conduct, data management and manufacturing​”, say the researchers.

Despite current shortcomings India has “a proven track record​” in some of these areas and has​“an enthusiasm to expand into services at the higher end of the value chain​”.

Related news

Show more

Related products

show more

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Related suppliers

1 comment

Is that research?

Posted by Dr Anupama Ramkumar,

I am surprised that this news brief quotes a 'review article' from a journal as research!!!

The article in focus adds nothing new,quotes redundant data and that too referenced from sources which are not direct producers of the data.
Basically stale wine in a not so new bottle!!

Report abuse

Follow us


View more